Browsing Category

Personal Finance Management

558 posts
ECB Publishes Consolidated Banking Data For end-March 2026

ECB Publishes Consolidated Banking Data For end-March 2026

The European Central Bank has published its latest consolidated banking statistics as of March 31, 2026, providing key insights into the euro area’s banking sector.
electronic lock box security

You Won’t Believe How Electronic Lock Box Can Secure Your Future

I never imagined an electronic lock box could transform security; discover how it can safeguard your future and why it’s worth exploring.
Launch HN: ProvenMetal (YC S26) Delivers Circuit Boards In Days Instead Of Weeks

Launch HN: ProvenMetal (YC S26) Delivers Circuit Boards In Days Instead Of Weeks

ProvenMetal, a YC S26 startup, now delivers assembled circuit boards in days instead of weeks, streamlining hardware prototyping and manufacturing.
hoverboard with seat stability

You Won’t Believe How Hoverboard With Seat Can Secure Your Future

Discover how a hoverboard with a seat can revolutionize your mobility and secure your future—find out what makes it so essential.
ARCPOINT ANNOUNCES FAILURE-TO-FILE CEASE TRADE ORDER

ARCPOINT ANNOUNCES FAILURE-TO-FILE CEASE TRADE ORDER

ArcPoint announced a cease trade order due to failure to file financial documents, raising concerns among investors and regulators.
Galibra Neuroscience Receives FDA Orphan Drug And Rare Pediatric Disease Designations For SSADH Deficiency Gene Therapy

Galibra Neuroscience Receives FDA Orphan Drug And Rare Pediatric Disease Designations For SSADH Deficiency Gene Therapy

Galibra Neuroscience receives FDA orphan drug and rare pediatric disease designations for its SSADH deficiency gene therapy, advancing its development pipeline.
AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, As Preclinical Candidate (PCC) For Ocular Diseases, Inflammatory Disorders And Aging

AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, As Preclinical Candidate (PCC) For Ocular Diseases, Inflammatory Disorders And Aging

Insilico Medicine announces ISM9077 as a potential first-in-class Y Inhibitor for ocular, inflammatory, and aging diseases, advancing AI-driven drug discovery.
sous vide cooking security

You Won’t Believe How Sous Vide Precision Cooker Can Secure Your Future

No other kitchen gadget can guarantee such precision and consistency—discover how a sous vide cooker can truly secure your culinary future.